Skip to main content
Fermentalg logo

Fermentalg — Investor Relations & Filings

Ticker · ALGAE ISIN · FR0011271600 LEI · 9695007VNRQR6V5TMN85 Euronext Growth Manufacturing
Open in API
Filings indexed 447 across all filing types
Latest filing 2026-05-13 Share Issue/Capital Cha…
Country FR France
Listing Euronext Growth ALGAE

About Fermentalg

https://www.fermentalg.com/

Fermentalg is an industrial biotechnology company that specializes in the research, development, and production of active ingredients derived from microalgae. Leveraging proprietary fermentation technology and sustainable bioprocesses, the company develops solutions primarily for the human nutrition and animal feed markets. Its main product lines include high-purity, vegan omega-3 oils rich in DHA (marketed as DHA ORIGINS®), alternative proteins, and natural colorants. Fermentalg's approach utilizes non-GMO microalgae and solvent-free extraction methods to offer sustainable, plant-based ingredients that cater to the growing demand for health and wellness products while addressing challenges in global food supply.

Recent filings

Filing Released Lang Actions
Succès d'une augmentation de capital de près de 11 MEUR en vue d'accélérer le développement commercial
Share Issue/Capital Change Classification · 90% confidence The document is a press release by Fermentalg announcing the successful completion of a €10.9 M capital increase through the issuance of 23.7 M new ordinary shares, describing the terms of the private placement and reserved offer, share pricing, shareholding impact, and related lock-up commitments. This is a direct announcement of a new share issue/capital change.
2026-05-13 French
Successful completion of a nearly EUR11 million capital increase to accelerate commercial development
Share Issue/Capital Change Classification · 90% confidence The document is a press release by Fermentalg announcing the successful completion of a €10.9 million capital increase through the issuance of 23,725,985 new ordinary shares, detailing transaction terms, share capital breakdown before and after the issue, lock-up undertakings, and related adviser information. This is a direct announcement of a new share issue and capital structure change—not an annual or interim report, not an earnings release, nor a general regulatory filing. Under the taxonomy, it best fits Share Issue/Capital Change (SHA).
2026-05-13 English
Launch of a capital increase with an indicative amount of approximately EUR10 million to accelerate commercial development
Capital/Financing Update Classification · 90% confidence The document is a press release by Fermentalg announcing the launch of a €10 million capital increase via a private placement and reserved offer, detailing subscription commitments, offer terms, pricing, and planned use of proceeds. This is an update on the company’s financing activities and capital structure, fitting squarely under a Capital/Financing Update rather than a full report or regulatory filing. Therefore, it should be classified as CAP.
2026-05-12 English
Lancement d'une augmentation de capital d'un montant indicatif d'environ 10 MEUR en vue d'accélérer le développement commercial
Share Issue/Capital Change Classification · 95% confidence The document is a press release announcing the launch of a capital increase (augmentation de capital) of approximately €10 M via the issuance of new shares through a private placement and a reserved offering. It details the terms, subscription commitments, pricing, number of shares, closing date, and regulatory framework for the share issue. This is a direct announcement of a new share issuance and change in capital structure, fitting the Share Issue/Capital Change category (SHA).
2026-05-12 French
Informations relatives au nombre total de droits de vote et d'actions
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document provides information about the total number of voting rights and shares of Fermentalg as of April 30, 2026, referencing specific articles of the French Commercial Code and the AMF regulations. It includes a table with share and voting rights counts and mentions a future publication date for half-year revenue. The content is focused on shareholder voting rights information rather than financial results, management changes, or detailed financial reports. The document length is short (2279 characters) and does not contain financial statements or detailed analysis. It is an official announcement related to voting rights, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-07 French
Succès de la stratégie de diversification des ventes au 1er trimestre 2026 et lancements commerciaux des nouvelles BioSolutions
Earnings Release Classification · 95% confidence The document is a press release presenting Fermentalg's unaudited revenue figures for the first quarter of 2026, highlighting commercial achievements, product launches, and future outlook. It contains no detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). Instead, it is a business update focusing on sales performance and commercial strategy. The document length is 5853 characters, which is relatively short and consistent with a financial or commercial update rather than a full report. There is no indication that this is a full quarterly report or annual report, nor is it a simple announcement of a report publication. Therefore, the best fitting category is Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. Q1 2026
2026-05-05 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.